Laura Tyson - Morgan Stanley Independent Director
| MS Stock | USD 92.83 0.27 0.29% |
Director
Dr. Laura DAndrea Tyson Ph.D. was Independent Director of Morgan Stanley. Dr. Tyson has served as a professor of Business Administration and Economics since 2013 and served as the S. K. and Angela Chan Professor of Global Management from 2008 to 2013 and as Professor of Business Administration and Economics from 2007 to 2008 at the Walter A. Haas School of Business University of California Berkeley. She was Dean of the London Business School from 2002 to 2006. Dr. Tyson was Dean from 1998 to 2001 and Class of 19 Professor in Economics and Business Administration from 1997 to 1998 at the Walter A. Haas School of Business University of California Berkeley. She served as National Economic Advisor to the President and Chair of the Presidents National Economic Council from 1995 to 1996 and as Chair of the White House Council of Economic Advisors from 1993 to 1995 since 1997.
| Age | 67 |
| Tenure | 27 years |
| Address | 1585 Broadway, New York, NY, United States, 10036 |
| Phone | 212 761 4000 |
| Web | https://www.morganstanley.com |
Morgan Stanley Management Efficiency
At this time, Morgan Stanley's Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.01 in 2024, whereas Return On Capital Employed is likely to drop 0.01 in 2024. At this time, Morgan Stanley's Other Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 719.5 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 22.6 B in 2024. Morgan Stanley's management efficiency ratios could be used to measure how well Morgan Stanley manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | DIRECTOR Age | ||
| David Spence | SAITECH Global | 63 | |
| Robert Aitken | SAITECH Global | N/A | |
| Iat Chan | SAITECH Global | 60 | |
| Andrew Jones | SAITECH Global | N/A | |
| Anne Scorey | SAITECH Global | N/A | |
| Chris Jouppi | SAITECH Global | N/A | |
| Cara Reil | SAITECH Global | N/A | |
| Jingchun Cui | SAITECH Global | N/A | |
| Anna Buduls | SAITECH Global | N/A | |
| Kim Jenkins | SAITECH Global | N/A | |
| Sylvia Falzon | SAITECH Global | 50 | |
| Zhiping Wang | SAITECH Global | N/A | |
| Tim Jacob | SAITECH Global | N/A | |
Management Performance
| Return On Equity | 0.0917 | ||||
| Return On Asset | 0.0078 |
Morgan Stanley Leadership Team
Elected by the shareholders, the Morgan Stanley's board of directors comprises two types of representatives: Morgan Stanley inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Morgan. The board's role is to monitor Morgan Stanley's management team and ensure that shareholders' interests are well served. Morgan Stanley's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Morgan Stanley's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Gorman, Chairman of the Board, Chief Executive Officer | ||
| Simon Evenson, Managing Director | ||
| Ryosuke Tamakoshi, Director | ||
| Judith Miscik, Independent Director | ||
| Mary Schapiro, Independent Director | ||
| Shelley Leibowitz, Independent Director | ||
| Hironori Kamezawa, Director | ||
| Erskine Bowles, Lead Independent Director | ||
| Erika James, Independent Director | ||
| Edward Pick, Head - Institutional Securities | ||
| Hutham Olayan, Independent Director | ||
| Stanislav Liberman, Managing Director | ||
| Eric Grossman, Chief Legal Officer, Executive Vice President | ||
| Jonathan Pruzan, Chief Financial Officer, Executive Vice President | ||
| Mandell Crawley, Chief Human Resource Officer | ||
| Marc Sgaraglino, Managing Director | ||
| James JD, COO | ||
| Patrick Willcutts, Corporate Retirement Director | ||
| Jami Miscik, Independent Director | ||
| James Boustead, Compliance Legal | ||
| Perry Traquina, Independent Director | ||
| Alistair Darling, Independent Director | ||
| Michael Pizzi, Head Technology | ||
| Stephen Popovchak, Managing Director | ||
| Sharon Yeshaya, Chief Financial Officer | ||
| Daniel Simkowitz, Head of Investment Management | ||
| Stephen Luczo, Independent Director | ||
| Thomas Glocer, Lead Independent Director | ||
| Simon Herrmann, Head Group | ||
| Sachin Wagle, CoHead India | ||
| Takeshi Ogasawara, Director | ||
| Donald Nicolaisen, Independent Director | ||
| Michael Wilson, Chief Officer | ||
| Dennis Nally, Independent Director | ||
| Rayford Wilkins, Independent Director | ||
| James Rosenthal, COO, Executive VP and Member of Operating Committee | ||
| Nobuyuki Hirano, Director | ||
| Sarah CFA, MD Centers | ||
| Andrew Saperstein, Head - Wealth Management | ||
| Robyn Goldschmid, Managing Director | ||
| Robert Herz, Independent Director | ||
| James Owens, Independent Director | ||
| Robert Rooney, Head of Technology - Operations and Firm Resilience | ||
| Colm Kelleher, Executive Vice President and Presidentident - Institutional Securities | ||
| Keishi Hotsuki, Executive Vice President, Chief Risk Officer | ||
| Laura Tyson, Independent Director | ||
| Jeffrey Brodsky, Chief Human Resource Officer, Executive Vice President | ||
| Elizabeth Corley, Independent Director | ||
| Raja Akram, Deputy Officer | ||
| Gregory Fleming, Executive Vice President and Presidentident - Asset Management and Presidentident - Global Wealth Management Group | ||
| Klaus Kleinfeld, Independent Director | ||
| Clint Gartin, Chairman Banking |
Morgan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Morgan Stanley a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0917 | ||||
| Return On Asset | 0.0078 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 37.95 B | ||||
| Shares Outstanding | 1.63 B | ||||
| Shares Owned By Insiders | 23.30 % | ||||
| Shares Owned By Institutions | 62.34 % | ||||
| Number Of Shares Shorted | 15.93 M | ||||
| Price To Earning | 13.51 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Morgan Stanley. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more information on how to buy Morgan Stock please use our How to Invest in Morgan Stanley guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Morgan Stock analysis
When running Morgan Stanley's price analysis, check to measure Morgan Stanley's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Morgan Stanley is operating at the current time. Most of Morgan Stanley's value examination focuses on studying past and present price action to predict the probability of Morgan Stanley's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Morgan Stanley's price. Additionally, you may evaluate how the addition of Morgan Stanley to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Morgan Stanley's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Morgan Stanley. If investors know Morgan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Morgan Stanley listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.188 | Dividend Share 3.4 | Earnings Share 5.5 | Revenue Per Share 33.686 | Quarterly Revenue Growth 0.06 |
The market value of Morgan Stanley is measured differently than its book value, which is the value of Morgan that is recorded on the company's balance sheet. Investors also form their own opinion of Morgan Stanley's value that differs from its market value or its book value, called intrinsic value, which is Morgan Stanley's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Morgan Stanley's market value can be influenced by many factors that don't directly affect Morgan Stanley's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Morgan Stanley's value and its price as these two are different measures arrived at by different means. Investors typically determine if Morgan Stanley is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Morgan Stanley's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.